{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:44:31Z","timestamp":1794523471870,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2018HH0062"],"award-info":[{"award-number":["2018HH0062"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2021YFH0187"],"award-info":[{"award-number":["2021YFH0187"]}]},{"name":"Medico-Engineering Cooperation Funds from University of Electronic Science and Technology of China","award":["ZYGX2021YGCX018"],"award-info":[{"award-number":["ZYGX2021YGCX018"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZYGX2020KYQD002"],"award-info":[{"award-number":["ZYGX2020KYQD002"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Liver fibrosis is a chronic liver disease with the presence of progressive wound healing response caused by liver injury. Currently, there are no approved therapies for liver fibrosis. Exosomes derived from human adipose mesenchymal stem cells (hADMSCs-Exo) have displayed a prominent therapeutic effect on liver diseases. However, few studies have evaluated therapeutic effect of hADMSCs-Exo in liver fibrosis and cirrhosis, and its precise mechanisms of action remain unclear. Herein, we investigated anti-fibrotic efficacy of hADMSCs-Exo in vitro and in vivo, and identified important metabolic changes and the detailed mechanism through transcriptomic and metabolomic profiling. We found hADMSCs-Exo could inhibit the proliferation of activated hepatic stellate cells through aggravating apoptosis and arresting G1 phase, effectively inhibiting the expression of profibrogenic proteins and epithelial-to-mesenchymal transition (EMT) in vitro. Moreover, it could significantly block collagen deposition and EMT process, improve liver function and reduce liver inflammation in liver cirrhosis mice model. The omics analysis revealed that the key mechanism of hADMSCs-Exo anti-hepatic fibrosis was the inhibition of PI3K\/AKT\/mTOR signaling pathway and affecting the changes of metabolites in lipid metabolism, and mainly regulating choline metabolism. CHPT1 activated by hADMSCs-Exo facilitated formation and maintenance of vesicular membranes. Thus, our study indicates that hADMSCs-Exo can attenuate hepatic stellate cell activation and suppress the progression of liver fibrosis, which holds the significant potential of hADMSCs-Exo for use as extracellular nanovesicles-based therapeutics in the treatment of liver fibrosis and possibly other intractable chronic liver diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-023-01788-4","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:04:08Z","timestamp":1674641048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism"],"prefix":"10.1186","volume":"21","author":[{"given":"Zilong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonglin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyou","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"1","key":"1788_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol."},{"issue":"2","key":"1788_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115(2):209\u201318.","journal-title":"J Clin Investig"},{"issue":"3","key":"1788_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40139-013-0019-6","volume":"1","author":"JX Jiang","year":"2013","unstructured":"Jiang JX, Torok NJ. Liver Injury and the Activation of the Hepatic Myofibroblasts. Curr Pathobiol Rep. 2013;1(3):215\u201323.","journal-title":"Curr Pathobiol Rep."},{"key":"1788_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","volume":"121","author":"G Mazza","year":"2017","unstructured":"Mazza G, Al-Akkad W, Rombouts K. Engineering in vitro models of hepatofibrogenesis. Adv Drug Deliv Rev. 2017;121:147\u201357.","journal-title":"Adv Drug Deliv Rev"},{"key":"1788_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fcell.2018.00150","volume":"6","author":"W Hou","year":"2018","unstructured":"Hou W, Syn WK. Role of metabolism in hepatic stellate cell activation and fibrogenesis. Front Cell Dev Biol. 2018;6:150.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"1788_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"O Khomich","year":"2019","unstructured":"Khomich O, Ivanov AV, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells. 2019;9(1):24.","journal-title":"Cells."},{"issue":"2","key":"1788_CR7","first-page":"388","volume":"70","author":"M Barcena-Varela","year":"2021","unstructured":"Barcena-Varela M, Paish H, Alvarez L, et al. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis. Gut. 2021;70(2):388\u2013400.","journal-title":"Gut."},{"issue":"1","key":"1788_CR8","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/s41467-018-04336-z","volume":"9","author":"M Asmani","year":"2018","unstructured":"Asmani M, Velumani S, Li Y, et al. Fibrotic microtissue array to predict anti-fibrosis drug efficacy. Nat Commun. 2018;9(1):2066.","journal-title":"Nat Commun."},{"issue":"6","key":"1788_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/lt.22228","volume":"17","author":"P Dutkowski","year":"2011","unstructured":"Dutkowski P, Oberkofler CE, Bechir M, et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl. 2011;17(6):674\u201384.","journal-title":"Liver Transpl."},{"issue":"3","key":"1788_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.15283\/ijsc18143","volume":"12","author":"D Sabry","year":"2019","unstructured":"Sabry D, Mohamed A, Monir M, Ibrahim HA. The effect of mesenchymal stem cells derived microvesicles on the treatment of experimental CCL4 induced liver fibrosis in rats. Int J Stem Cells. 2019;12(3):400\u20139.","journal-title":"Int J Stem Cells."},{"key":"1788_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","volume":"39","author":"A Tsuchiya","year":"2019","unstructured":"Tsuchiya A, Takeuchi S, Watanabe T, et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \u201cconducting cells\u201d for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39:18.","journal-title":"Inflamm Regen."},{"issue":"8","key":"1788_CR12","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann Transl Med. 2020;8(8):562.","journal-title":"Ann Transl Med."},{"issue":"6","key":"1788_CR13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","volume":"15","author":"M Shi","year":"2021","unstructured":"Shi M, Li YY, Xu RN, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial. Hepatol Int. 2021;15(6):1431\u201341.","journal-title":"Hepatol Int."},{"issue":"5","key":"1788_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/biof.1374","volume":"43","author":"V Volarevic","year":"2017","unstructured":"Volarevic V, Gazdic M, Simovic Markovic B, Jovicic N, Djonov V, Arsenijevic N. Mesenchymal stem cell-derived factors: immuno-modulatory effects and therapeutic potential. Biofactors. 2017;43(5):633\u201344.","journal-title":"Biofactors."},{"issue":"1\u20134","key":"1788_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trim.2013.08.004","volume":"29","author":"M Koch","year":"2013","unstructured":"Koch M, Lehnhardt A, Hu X, et al. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transpl Immunol. 2013;29(1\u20134):43\u201350.","journal-title":"Transpl Immunol."},{"issue":"1","key":"1788_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3350\/cmh.2020.0194","volume":"27","author":"Y Watanabe","year":"2021","unstructured":"Watanabe Y, Tsuchiya A, Terai S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol. 2021;27(1):70\u201380.","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"1788_CR17","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijms15034142","volume":"15","author":"B Yu","year":"2014","unstructured":"Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15(3):4142\u201357.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"1788_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/BST20120192","volume":"41","author":"G Camussi","year":"2013","unstructured":"Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochem Soc Trans. 2013;41(1):283\u20137.","journal-title":"Biochem Soc Trans."},{"key":"1788_CR19","doi-asserted-by":"publisher","first-page":"5310202","DOI":"10.1155\/2019\/5310202","volume":"2019","author":"K Yuan","year":"2019","unstructured":"Yuan K, Lai C, Wei L, et al. the effect of vascular endothelial growth factor on bone marrow mesenchymal stem cell engraftment in rat fibrotic liver upon transplantation. Stem Cells Int. 2019;2019:5310202.","journal-title":"Stem Cells Int."},{"issue":"4","key":"1788_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00535-021-01765-4","volume":"56","author":"Y Shi","year":"2021","unstructured":"Shi Y, Du L, Lv D, et al. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J Gastroenterol. 2021;56(4):336\u201349.","journal-title":"J Gastroenterol."},{"key":"1788_CR21","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.","journal-title":"J Extracell Vesicles."},{"issue":"6","key":"1788_CR22","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/hep.28814","volume":"64","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Verma VK, et al. Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology. 2016;64(6):2219\u201333.","journal-title":"Hepatology."},{"key":"1788_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2018.01.022","volume":"273","author":"DA Borrelli","year":"2018","unstructured":"Borrelli DA, Yankson K, Shukla N, Vilanilam G, Ticer T, Wolfram J. Extracellular vesicle therapeutics for liver disease. J Control Release. 2018;273:86\u201398.","journal-title":"J Control Release"},{"issue":"10","key":"1788_CR24","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/liv.14189","volume":"39","author":"A Balaphas","year":"2019","unstructured":"Balaphas A, Meyer J, Sadoul R, Morel P, Gonelle-Gispert C, Buhler LH. Extracellular vesicles: Future diagnostic and therapeutic tools for liver disease and regeneration. Liver Int. 2019;39(10):1801\u201317.","journal-title":"Liver Int."},{"key":"1788_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jconrel.2020.01.042","volume":"320","author":"HS Han","year":"2020","unstructured":"Han HS, Lee H, You D, et al. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J Control Release. 2020;320:328\u201336.","journal-title":"J Control Release"},{"issue":"3","key":"1788_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12031-010-9446-6","volume":"44","author":"N Ahmadian Kia","year":"2011","unstructured":"Ahmadian Kia N, Bahrami AR, Ebrahimi M, et al. Comparative analysis of chemokine receptor\u2019s expression in mesenchymal stem cells derived from human bone marrow and adipose tissue. J Mol Neurosci. 2011;44(3):178\u201385.","journal-title":"J Mol Neurosci."},{"issue":"11","key":"1788_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","volume":"21","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues G, Hoshino A, Kenific CM, et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat Cell Biol. 2019;21(11):1403\u201312.","journal-title":"Nat Cell Biol."},{"issue":"3","key":"1788_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/hep.28918","volume":"65","author":"VL Massey","year":"2017","unstructured":"Massey VL, Dolin CE, Poole LG, et al. The hepatic \u201cmatrisome\u201d responds dynamically to injury: characterization of transitional changes to the extracellular matrix in mice. Hepatology. 2017;65(3):969\u201382.","journal-title":"Hepatology."},{"issue":"6","key":"1788_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev."},{"issue":"3","key":"1788_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","volume":"508","author":"L Jiang","year":"2019","unstructured":"Jiang L, Zhang S, Hu H, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. Biochem Biophys Res Commun. 2019;508(3):735\u201341.","journal-title":"Biochem Biophys Res Commun."},{"issue":"3","key":"1788_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","volume":"71","author":"Z Xie","year":"2022","unstructured":"Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2022;71(3):568\u201379.","journal-title":"Gut."},{"issue":"1","key":"1788_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng L, Mohan T, Chang TZ, et al. Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nat Commun. 2018;9(1):359.","journal-title":"Nat Commun."},{"key":"1788_CR33","doi-asserted-by":"publisher","first-page":"131103","DOI":"10.1016\/j.foodchem.2021.131103","volume":"371","author":"Q Huang","year":"2022","unstructured":"Huang Q, Dong K, Wang Q, et al. Changes in volatile flavor of yak meat during oxidation based on multi-omics. Food Chem. 2022;371:131103.","journal-title":"Food Chem."},{"issue":"2","key":"1788_CR34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/hep4.1290","volume":"3","author":"L Chen","year":"2019","unstructured":"Chen L, Brenner DA, Kisseleva T. Combatting fibrosis: exosome-based therapies in the regression of liver fibrosis. Hepatol Commun. 2019;3(2):180\u201392.","journal-title":"Hepatol Commun."},{"issue":"6","key":"1788_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.63","volume":"49","author":"G Lou","year":"2017","unstructured":"Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6): e346.","journal-title":"Exp Mol Med."},{"issue":"10","key":"1788_CR36","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181\u20135p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21(10):2491\u2013502.","journal-title":"J Cell Mol Med."},{"issue":"34","key":"1788_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ebiom.2018.07.015","volume":"2018","author":"Y Jin","year":"2018","unstructured":"Jin Y, Wang J, Li H, et al. Extracellular vesicles secreted by human adipose-derived stem cells (hASCs) improve survival rate of rats with acute liver failure by releasing lncRNA H19. EBioMedicine. 2018;2018(34):231\u201342.","journal-title":"EBioMedicine"},{"key":"1788_CR38","doi-asserted-by":"publisher","first-page":"853506","DOI":"10.1155\/2015\/853506","volume":"2015","author":"SF Ko","year":"2015","unstructured":"Ko SF, Yip HK, Zhen YY, et al. Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer T-cell responses, and histopathological features. Stem Cells Int. 2015;2015:853506.","journal-title":"Stem Cells Int."},{"issue":"36","key":"1788_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ebiom.2018.08.054","volume":"2018","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lou G, Li A, et al. AMSC-derived exosomes alleviate lipopolysaccharide\/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP\/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;2018(36):140\u201350.","journal-title":"EBioMedicine"},{"key":"1788_CR40","doi-asserted-by":"publisher","first-page":"6079642","DOI":"10.1155\/2018\/6079642","volume":"2018","author":"W Jiang","year":"2018","unstructured":"Jiang W, Tan Y, Cai M, et al. Human umbilical cord MSC-derived exosomes suppress the development of CCl4-induced liver injury through antioxidant effect. Stem Cells Int. 2018;2018:6079642.","journal-title":"Stem Cells Int."},{"issue":"1","key":"1788_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/beta-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.","journal-title":"Stem Cell Res Ther."},{"issue":"4","key":"1788_CR42","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1096\/fj.201902307RRR","volume":"34","author":"L Chen","year":"2020","unstructured":"Chen L, Yao X, Yao H, Ji Q, Ding G, Liu X. Exosomal miR-103\u20133p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells. FASEB J. 2020;34(4):5178\u201392.","journal-title":"FASEB J."},{"issue":"1","key":"1788_CR43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/10717544.2022.2030428","volume":"29","author":"L Ma","year":"2022","unstructured":"Ma L, Wei J, Zeng Y, et al. Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141\u20133p\/PTEN\/AKT pathway in human liver fibrosis. Drug Deliv. 2022;29(1):440\u201353.","journal-title":"Drug Deliv."},{"issue":"2","key":"1788_CR44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun R, Lopategi A, George J, et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling. Hepatology. 2012;55(2):594\u2013608.","journal-title":"Hepatology."},{"issue":"5","key":"1788_CR45","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinre.2019.02.003","volume":"43","author":"Y Lei","year":"2019","unstructured":"Lei Y, Wang QL, Shen L, Tao YY, Liu CH. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway. Clin Res Hepatol Gastroenterol. 2019;43(5):575\u201384.","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"5","key":"1788_CR46","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/hep.23186","volume":"50","author":"G Son","year":"2009","unstructured":"Son G, Hines IN, Lindquist J, Schrum LW, Rippe RA. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology. 2009;50(5):1512\u201323.","journal-title":"Hepatology."},{"issue":"5","key":"1788_CR47","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/hep.28286","volume":"63","author":"M Pauta","year":"2016","unstructured":"Pauta M, Rotllan N, Fernandez-Hernando A, et al. Akt-mediated foxo1 inhibition is required for liver regeneration. Hepatology. 2016;63(5):1660\u201374.","journal-title":"Hepatology."},{"issue":"17","key":"1788_CR48","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JS Yu","year":"2016","unstructured":"Yu JS, Cui W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development. 2016;143(17):3050\u201360.","journal-title":"Development."},{"issue":"1","key":"1788_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCRESAHA.115.304457","volume":"116","author":"Z Lin","year":"2015","unstructured":"Lin Z, Zhou P, von Gise A, et al. Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res. 2015;116(1):35\u201345.","journal-title":"Circ Res."},{"issue":"4","key":"1788_CR50","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30662","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu R, Li X, Zhu W, et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis. Hepatology. 2019;70(4):1317\u201335.","journal-title":"Hepatology."},{"issue":"7642","key":"1788_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450\u20135.","journal-title":"Nature."},{"issue":"2","key":"1788_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012;28(2):159\u201365.","journal-title":"Curr Opin Gastroenterol."},{"issue":"5\u20136","key":"1788_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.mito.2008.07.008","volume":"8","author":"JS Teodoro","year":"2008","unstructured":"Teodoro JS, Rolo AP, Duarte FV, Simoes AM, Palmeira CM. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion. 2008;8(5\u20136):367\u201376.","journal-title":"Mitochondrion."},{"issue":"9","key":"1788_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024084","volume":"6","author":"S Gaetani","year":"2011","unstructured":"Gaetani S, Serviddio G, Giudetti AM, et al. Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS ONE. 2011;6(9): e24084.","journal-title":"PLoS ONE."},{"key":"1788_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1005628121546","volume":"46","author":"AL Buchman","year":"2001","unstructured":"Buchman AL. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci. 2001;46:1\u201318.","journal-title":"Dig Dis Sci."},{"issue":"1","key":"1788_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-016-0318-8","volume":"8","author":"JC Schoeman","year":"2016","unstructured":"Schoeman JC, Hou J, Harms AC, et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Med. 2016;8(1):64.","journal-title":"Genome Med."},{"key":"1788_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jpba.2016.06.033","volume":"129","author":"YH Liang","year":"2016","unstructured":"Liang YH, Tang CL, Lu SY, et al. Serum metabonomics study of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride-induced acute hepatotoxicity in rats by (1)H NMR analysis. J Pharm Biomed Anal. 2016;129:70\u20139.","journal-title":"J Pharm Biomed Anal"},{"issue":"118","key":"1788_CR58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jpba.2015.10.026","volume":"2016","author":"QY Niu","year":"2016","unstructured":"Niu QY, Li ZY, Du GH, Qin XM. (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model. J Pharm Biomed Anal. 2016;2016(118):338\u201348.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"1788_CR59","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1556-276X-8-236","volume":"8","author":"B Lin","year":"2013","unstructured":"Lin B, Zhang H, Lin Z, et al. Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts. Nanoscale Res Lett. 2013;8(1):236.","journal-title":"Nanoscale Res Lett"},{"key":"1788_CR60","doi-asserted-by":"publisher","first-page":"122202","DOI":"10.1016\/j.jchromb.2020.122202","volume":"1152","author":"B Zeng","year":"2020","unstructured":"Zeng B, Su M, Chen Q, Chang Q, Wang W, Li H. Anoectochilus roxburghii polysaccharide prevents carbon tetrachloride-induced liver injury in mice by metabolomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1152:122202.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"issue":"3","key":"1788_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3945\/jn.113.185389","volume":"144","author":"A Al Rajabi","year":"2014","unstructured":"Al Rajabi A, Castro GS, da Silva RP, et al. Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt\/Ldlr knockout mice fed a high-fat diet. J Nutr. 2014;144(3):252\u20137.","journal-title":"J Nutr."},{"issue":"4","key":"1788_CR62","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.7150\/thno.69885","volume":"12","author":"F He","year":"2022","unstructured":"He F, Li WN, Li XX, et al. Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice. Theranostics. 2022;12(4):1816\u201328.","journal-title":"Theranostics."},{"issue":"5","key":"1788_CR63","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim HJ, et al. Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174\u201386.","journal-title":"Gastroenterology."},{"issue":"11","key":"1788_CR64","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou G, Yang Y, Liu F, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21(11):2963\u201373.","journal-title":"J Cell Mol Med."},{"key":"1788_CR65","doi-asserted-by":"publisher","first-page":"38498","DOI":"10.1038\/srep38498","volume":"6","author":"A Reza","year":"2016","unstructured":"Reza A, Choi YJ, Yasuda H, Kim JH. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep. 2016;6:38498.","journal-title":"Sci Rep."}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01788-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01788-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01788-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T11:04:54Z","timestamp":1674644694000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01788-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01788-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2031107\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants and all mouse experimental protocols were reviewed and approved by the Institutional Review Board for Clinical Research and Animal Ethics Committee of Sichuan Provincial People\u2019s Hospital (No. 2021448). The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}